IDEX Biometrics ASA
IDXAF
$0.002
$0.001100.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.40% | -373.53% | 120.39% | -23.04% | -10.21% |
| Total Depreciation and Amortization | -68.78% | 217.87% | -134.09% | 187.96% | -24.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 131.02% | 52.15% | -1,111.26% | 226.00% | -162.48% |
| Change in Net Operating Assets | -80.57% | 18.11% | 53,250.00% | 99.72% | -2,807.69% |
| Cash from Operations | 18.77% | -46.82% | 54.78% | 26.63% | -86.40% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -91.36% | 1,520.00% | -58.33% | -80.33% | 52.50% |
| Cash from Investing | 133.33% | 112.00% | -110.04% | 441.30% | 15.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 10.58% | 82.22% | 44.39% | 30.47% | -307.82% |
| Issuance of Common Stock | -- | 130.65% | -61.04% | 15,648.39% | -98.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -59.00% | 225.21% | -65.39% | 356.75% | -113.08% |
| Foreign Exchange rate Adjustments | 144.44% | -181.82% | 266.67% | 150.00% | -160.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -202.04% | 195.39% | 0.71% | 88.17% | -208.07% |